The prevalence of hypertension and hyperlipidemia with risk for cardiovascular disease, coronary artery disease and left ventricular hypertrophy is higher in chronic kidney disease compared to the general population. Serum potassium should be monitored because of the effect of some antihypertensive agents on potassium excretion.